Prediction: 3 Reasons SpaceX Could Fall 50% Over the Next Year

This is less a fundamental research story than a market-structure event: once a stock is priced as a near-perfect exponential, the marginal buyer becomes extremely rate-sensitive and any supply hitting the tape can reset the clearing price fast. The real risk is not a single earnings miss; it is that the market is forced to mark a long-duration asset against nearer-term dilution, capex, and financing needs before the growth curve can validate the multiple.

The key second-order effect is precedent. If this name trades poorly through the first secondary window, it will cool demand for other “pre-profit, world-changing” listings and tighten the discount demanded for late-stage private rounds. That matters for venture portfolios and for any listed peer whose valuation is anchored more to narrative than cash generation; the market will likely punish the whole category before it fully differentiates winners from stories.

Timing matters: the next 1-3 months are about supply overhang and post-earnings guidance credibility, while the 6-18 month debate is whether the business can outrun its capital intensity enough to justify a premium multiple. The bearish thesis fails if insider selling is modest, lockups are staged quietly, and revenue growth is visibly converting into operating leverage faster than expected. Also, lower real rates would mechanically support the valuation and make shorts expensive to carry.

Contrarian take: the consensus may be overestimating how quickly public-market liquidity translates into downside. Scarcity, retail enthusiasm, and index inclusion can keep an extreme multiple elevated longer than models expect, especially if the float remains effectively constrained. In other words, the stock can stay detached from fundamentals until the market gets a concrete supply shock or an execution miss, not just because the narrative sounds implausible.